Bitcoin options open interest increased by 1.40% to $28.72 billion, with 24-hour trading volume reaching $2.23 billion. Calls made up 57.87% of open interest and 52.97% of daily volume, indicating a preference for upside exposure, but puts still held a substantial share, reflecting demand for downside protection. The most active contracts were high-strike calls and puts expiring in late 2026, showing mixed investor strategies. This balance suggests traders are hedging while seeking gains amid market uncertainty.
Bitcoin options open interest and volume provide context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang as of Nov 02, 2026 18:41 WIB: out of 50 priced assets, only 5 rose while 44 fell. Among notable movers, ONE (Harmony) dropped 4.40% to Rp20 with a typical hold time of 154 days and a buy order share of 58%, contrasting with EGLD (MultiversX) which fell 3.99% to Rp60,369 and saw 95% sell orders. AAVE (Aave) also declined 4.30% to Rp2,377,797 with 72% sell orders and a shorter hold time of 106 days.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
